We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · June 20, 2021

Conventional and New Pharmaceutical Use for Hemophilia Treatments in Medicaid Enrollees

JAMA Network Open


Additional Info

JAMA Network Open
Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020
JAMA Netw Open 2021 Jun 01;4(6)e2112044, I Hernandez, D Rowe, WF Gellad, CB Good

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading